Ohmori T - Search Results

1

Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis.

Ando K, Akimoto K, Sato H, Manabe R, Kishino Y, Homma T, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Sagara H. Ando K, et al. Among authors: ohmori t. Cancers (Basel). 2020 Apr 10;12(4):942. doi: 10.3390/cancers12040942. Cancers (Basel). 2020. PMID: 32290309 Free PMC article. Review.

2

Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer.

Hirose T, Horichi N, Ohmori T, Shirai T, Sohma S, Yamaoka T, Ohnishi T, Adachi M. Hirose T, et al. Among authors: ohmori t. Lung Cancer. 2003 Jan;39(1):91-7. doi: 10.1016/s0169-5002(02)00305-7. Lung Cancer. 2003. PMID: 12499100 Clinical Trial.

3

Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinib.

Ando K, Ohmori T, Inoue F, Kadofuku T, Hosaka T, Ishida H, Shirai T, Okuda K, Hirose T, Horichi N, Nishio K, Saijo N, Adachi M, Kuroki T. Ando K, et al. Among authors: ohmori t. Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8872-9. doi: 10.1158/1078-0432.CCR-05-0811. Clin Cancer Res. 2005. PMID: 16361577

4

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer.

Hirose T, Shirai T, Ishida H, Ando K, Sugiyama T, Kusumoto S, Hosaka T, Nakashima M, Ohmori T, Adachi M. Hirose T, et al. Among authors: ohmori t. Cancer Chemother Pharmacol. 2007 Jul;60(2):267-74. doi: 10.1007/s00280-006-0369-4. Epub 2007 Feb 2. Cancer Chemother Pharmacol. 2007. PMID: 17273827 Clinical Trial.

5

Phase I study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.

Okuda K, Hirose T, Ishida H, Kusumoto S, Sugiyama T, Ando K, Shirai T, Ohnishi T, Horichi N, Ohmori T, Adachi M. Okuda K, et al. Among authors: ohmori t. Cancer Chemother Pharmacol. 2008 Apr;61(5):829-35. doi: 10.1007/s00280-007-0540-6. Epub 2007 Jun 23. Cancer Chemother Pharmacol. 2008. PMID: 17589845 Clinical Trial.

6

Mutant epidermal growth factor receptor undergoes less protein degradation due to diminished binding to c-Cbl.

Hosaka T, Inoue F, Ando K, Ishida H, Kusumoto S, Sugiyama T, Shirai T, Okuda K, Hirose T, Ohnishi T, Horichi N, Saijo N, Adachi M, Nakadate T, Kuroki T, Ohmori T. Hosaka T, et al. Among authors: ohmori t. Anticancer Res. 2007 Jul-Aug;27(4B):2253-63. Anticancer Res. 2007. PMID: 17695511 Free article.

7

Effectiveness of intensive follow-up after response in patients with small cell lung cancer.

Sugiyama T, Hirose T, Hosaka T, Kusumoto S, Nakashima M, Yamaoka T, Okuda K, Ohmori T, Adachi M. Sugiyama T, et al. Among authors: ohmori t. Lung Cancer. 2008 Feb;59(2):255-61. doi: 10.1016/j.lungcan.2007.08.016. Epub 2007 Sep 27. Lung Cancer. 2008. PMID: 17900754

8

Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.

Hirose T, Yamaoka T, Ohnishi T, Sugiyama T, Kusumoto S, Shirai T, Okuda K, Ohmori T, Adachi M. Hirose T, et al. Among authors: ohmori t. Psychooncology. 2009 May;18(5):483-9. doi: 10.1002/pon.1450. Psychooncology. 2009. PMID: 18942662

9

Phase II study of the combination of nedaplatin and weekly paclitaxel in patients with advanced non-small cell lung cancer.

Hirose T, Sugiyama T, Kusumoto S, Shirai T, Nakashima M, Yamaoka T, Okuda K, Ogura K, Ohnishi T, Ohmori T, Adachi M. Hirose T, et al. Among authors: ohmori t. Anticancer Res. 2009 May;29(5):1733-8. Anticancer Res. 2009. PMID: 19443395 Free article. Clinical Trial.

10

Combination effect between bortezomib and tumor necrosis factor alpha on gefitinib-resistant non-small cell lung cancer cell lines.

Kusumoto S, Sugiyama T, Ando K, Hosaka T, Ishida H, Shirai T, Yamaoka T, Okuda K, Hirose T, Ohnishi T, Inoue F, Kanome T, Kadofuku T, Saijo N, Adachii M, Ohmori T. Kusumoto S, et al. Among authors: ohmori t. Anticancer Res. 2009 Jun;29(6):2315-22. Anticancer Res. 2009. PMID: 19528497 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

826 results

Search Page

Filters